Tag:
molecular diagnostics
Latest Headlines
Latest Headlines
Cancer Genetics' IPO delayed amid Facebook frenzy
Seeking Alpha reasoned this week that Cancer Genetics' IPO might be small enough to slip through even though Wall Street has been bracing for the blockbuster maiden offering of Facebook. Guess not.
Agilent jumps into molecular diagnostics with $2.2B Dako deal
Denmark's Dako shows once again why molecular diagnostics are the life sciences segment to watch this year. Agilent Technologies ($A) has inked a deal to pay $2.2 billion for the cancer diagnostic tools company in a bid to boost its growth in the space.
Genomic Health, OncoMed to pursue companion diagnostics
Genomic Health and OncoMed Pharmaceuticals have an agreement to identify new biomarkers useful for future companion diagnostics that would go along with OncoMed's cancer drugs now in development.
Hologic to absorb Gen-Probe in $3.7B bid to be major STD diagnostics player
Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with its planned $3.7 billion cash acquisition of Gen-Probe ($GPRO).
Qiagen's molecular diagnostics buys boost Q1 sales
Qiagen finished its fiscal 2012 first quarter with double-digit growth in both sales and net income, driven by acquisitions and a booming demand for diagnostic test kits.
Spurned by Illumina, Roche may be eyeing universities for gene-sequencing tech
Roche ($RHHBY) is bound and determined to boost its presence in the molecular diagnostics business. Days after giving up on its $6.7 billion hostile bid for Illumina ($ILMN), a newspaper is reporting the drugmaker may be turning to intellectual property at three universities in its push to acquire gene-sequencing technology.
Roche's bid for Illumina may be kaput
After an apparently unsuccessful attempt to stack Illumina's board in its favor, Roche appears to be heading toward ending its $51-per-share, $6.7 billion bid for the California company.
Diagnostics startups Vivia, Molecular Detection raise millions
Startups Vivia Biotech in Spain and Molecular Detection in the U.S. have nailed down new funding toward advancing clinical trials and ongoing product development.
CyVek nails down $3M for diagnostics test system
Connecticut startup CyVek has nailed down $3 million in new funding toward development of a test system designed to handle molecular diagnostics, immunodiagnostics and bioassays for both drug discovery and clinical care use, MassHighTech is reporting.
GE Healthcare ups molecular diagnostics game
GE Healthcare is upping its game in a bid to develop new, targeted molecular diagnostics.
